The medtech segment achieved operational revenue growth of 4.4% despite ongoing weaknesses in the Chinese market. Notably, ...

We recently compiled a list of the Best Future Stocks For The Long-Term. In this article, we will look at where Johnson & ...

Johnson & Johnson ($JNJ) is escalating its efforts to resolve the long-running talc lawsuit by agreeing to pay an additional ...

Johnson & Johnson has announced that the US FDA has approved TREMFYA for the treatment of active ulcerative colitis (UC).

Why? Simply because the valuation and growth numbers tell us so. DaVita and Duke Energy stocks have both seen higher growth in revenue and operating profits than Johnson & Johnson in the last twelve ...

After examining Johnson & Johnson, the following trends can be inferred: A Price to Earnings ratio of 24.93 significantly below the industry average by 0.75x suggests undervaluation. This can make the ...

The share of Iowa Democrats who feel optimistic about the presidential election has grown dramatically since Kamala Harris ...

Advancements and Projections in the Medical Tapes and Bandages Market: Insights, Trends, Opportunities, and Recent ...

The FBI investigates the attempted assassination of Donald Trump at his Florida golf club. House Republicans will attempt to ...

Advancements and Projections in the Pediatric Medical Device Market: Insights, Trends, Opportunities, and Recent ...